Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation

Key Points Vancomycin exposure in the pre-engraftment period was associated with an increased risk for CMV reactivation after allogeneic HCT. Some gram-positive bacteria may protect against CMV reactivation.